When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Coagulação intravascular disseminada

Evidence last reviewed: 19 Oct 2026
Topic last updated: 08 Jul 2026

Summary

Definition

História e exame físico

Principais fatores diagnósticos

  • presença de doenças subjacentes
  • oligúria, hipotensão ou taquicardia
  • delirium ou coma
  • petéquias, equimose, exsudação ou hematúria
Detalhes completos

Outros fatores diagnósticos

  • púrpura fulminante, gangrena ou cianose acral
Detalhes completos

Fatores de risco

  • Sepse/infecção grave
  • destruição ou insuficiência grave de órgãos
  • choque
  • distúrbios ou complicações obstétricas
  • tumores sólidos e malignidades hematológicas
  • reações tóxicas ou imunológicas graves
  • doenças vasculares graves (grandes aneurismas da aorta ou hemangiomas gigantes)
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • contagem plaquetária
  • tempo de protrombina (TP)/razão normalizada internacional (INR)
  • fibrinogênio
  • dímero D/produtos de degradação da fibrina
  • tempo de tromboplastina parcial ativada (TTPa)
  • estudos de imagem ou outros exames
Detalhes completos

Investigações a serem consideradas

  • tempo de trombina
  • antitrombina
Detalhes completos

Algoritmo de tratamento

AGUDA

baixo risco de sangramento

alto risco de sangramento ou sangramento ativo

CONTÍNUA

coagulação intravascular disseminada crônica

Colaboradores

Autores

Jerrold Levy, MD, FAHA, FCCM

Emeritus Professor of Anesthesiology, Critical Care, and Surgery (Cardiothoracic)

Duke University School of Medicine

Adjunct Professor

Department of Pathology & Laboratory Medicine

Faculty of Medicine at the UBC Vancouver Campus

Durham, NC

Disclosures

JHL receives honoraria for research advisory steering committees for Bayer, Grifols, Octapharma, and Werfen that are unrelated to considerations for disseminated intravascular coagulation.

Toshiaki Iba, MD

Department of Emergency and Critical Care Medicine

Juntendo University

Japan

Disclosures

TI declares that he has no competing interests.

Marcel Levi, MD, PhD

Professor of Medicine

University College London Hospitals NHS Foundation Trust

London

UK

Disclosures

ML declares that he has no competing interests.

Acknowledgements

Dr Jerrold Levy, Dr Toshiaki Iba, and Dr Marcel Levi would like to gratefully acknowledge Dr Frank G. Zavisca and Dr Haibo Wang, previous contributors to this topic.

Disclosures

FGZ and HW declare that they have no competing interests.

Peer reviewers

Pavan Bendapudi, MD

Assistant Professor of Medicine

Harvard Medical School

Boston, MA

Disclosures

PB declares that he has no competing interests.

Cheng-Hock Toh, MB, ChB, MD, FRCP, FRCPath

Professor of Haematology

University of Liverpool

Liverpool

UK

Disclosures

CHT is an author of a reference cited in this topic.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Squizzato A, Gallo A, Levi M, et al. Underlying disorders of disseminated intravascular coagulation: communication from the ISTH SSC subcommittees on disseminated intravascular coagulation and perioperative and critical care thrombosis and hemostasis. J Thromb Haemost. 2020 Sep;18(9):2400-7.Full text  Abstract

Iba T, Helms J, Connors JM, et al. The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation. J Intensive Care. 2023 May 23;11(1):24.Full text  Abstract

Iba T, Levi M, Thachil J, et al. Disseminated intravascular coagulation: the past, present, and future considerations. Semin Thromb Hemost. 2022 Nov;48(8):978-87. Abstract

Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018 Feb 22;131(8):845-54.Full text  Abstract

Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009 Apr;145(1):24-33.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Differentials

    • Insuficiência hepática grave
    • Trombocitopenia induzida por heparina
    • Deficiência de vitamina K
    More Differentials
  • Guidelines

    • The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition
    • Supportive management strategies for disseminated intravascular coagulation. An international consensus
    More Guidelines
  • Patient information

    Coagulação intravascular disseminada

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer